Aubra Eq Kit
Product Images NDC 63629-5651

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aubra Eq (NDC 63629-5651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636295651)

The text is a description of a medication called Aubra EQ which contains levonorgestrel and ethinyl estradiol. Each tablet contains 0.1 mg of levonorgestrel USP and 0.02 mg of ethinyl estradiol USP. It provides information on dosage, storage guidelines, manufacturer details, and a recommendation to keep the package out of reach of children due to lack of child resistance.*

FDA Label Image

Figure I: Mean (se) Levonorgestrel And Ethinyl Estradiol Serum Concentrations In 22 Subjects Receiving Levonorgestrel And Ethinyl Estradiol (100 Mcg Levonorgestrel And 20 Mcg Ethinyl Estradiol) (Levo Ethi Fig1)

FDA Label Image

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral-contraceptive Use (Levo Ethi Fig2)

FDA Label Image

Levo-ethi-fig3 (Levo Ethi Fig3)

The text provided includes mentions of various studies related to women's health and contraceptive use, such as the NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, Nurses Health Study, and Oxford Family Planning Association Study. It also indicates the years these studies were conducted and whether they focused on ever or current use of contraceptives. Additionally, there are effect estimates (OR/AR) included in the text.*

FDA Label Image

Levo-ethi-fig4 (Levo Ethi Fig4)

This is a product label for Aubra EQ®, containing Levonorgestrel and Ethinyl Estradiol in tablet form. The tablets may be white to off-white in color. The label indicates that tablets in week 4 are inactive.*

FDA Label Image

Levo-ethi-fig5 (Levo Ethi Fig5)

This text provides instructions for identifying the correct day label for different colored pills, specifically white to off-white and green. It also mentions placing a label and following instructions along with the days of the week listed for reference. Additionally, it features a specific medication name and dosage information for tablets in week 4.*

FDA Label Image

Levo-ethi-fig6 (Levo Ethi Fig6)

This is a label from a pack of birth control pills named "Aubra EQ" containing Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg. The pills in week 4 are inactive and colored white to off-white. The packaging includes arrows to indicate the days of the week.*

FDA Label Image

Levo-ethi-fig7 (Levo Ethi Fig7)

This text provides instructions for placing labels on different days of the week for a specific medication. The labels seem to be either white or off-white in color, and there are some green labels as well. The specific medication mentioned is Aubra EQ® which contains Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg. The labels should be placed according to the days of the week (MON, TUE, WED, THU, FRI, SAT, SUN).*

FDA Label Image

Chemical Structure (Levo Ethi Str)

Ethinyl Estradiol*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.